Latest stories on ONC
BeOne Medicines expands New Jersey campus with additional $300 million investment (NASDAQ:ONC)
InvestorsHub63 · neutralgeneral
BeOne expands U.S. footprint with $300M investment in New Jersey
Seeking Alpha63 · neutralgeneral
BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5 | ONC Stock News
StockTitan50 · neutralgeneral
BeOne Medicines Advances Minority-Focused Cancer Trial With Tislelizumab Combo
TipRanks63 · neutralproduct/pr
Is BeOne Medicines AG (ONC) Stock Positioned for Growth After Encouraging ASCO Cancer Data?
Yahoo Top67 · bullishanalyst
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma | ONC Stock News
StockTitan73 · bullishproduct/pr
BeOne Medicines Ltd. (BEIGF) files 8-K
SEC 8-K50 · neutralgeneral
Here is Why BeOne (ONC) One of the Most Promising Long-Term Stocks to Buy According to Analysts
Yahoo Finance63 · neutralanalyst
BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline
Yahoo Top67 · bullishanalyst
BeOne Medicines (ONC) Presents Updated BRUKINSA Phase 3 Data at EHA
Yahoo Top67 · bullishproduct/pr
BeOne Medicines Advances BGB-58067 With Key Drug-Interaction Study in Healthy Volunteers
TipRanks59 · neutralproduct/pr
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 | ONC Stock News
StockTitan73 · bullishproduct/pr
BeOne Medicines Ltd. (BEIGF) files 8-K
SEC 8-K50 · neutralgeneral
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit | ONC Stock News
StockTitan67 · bullishproduct/pr
BeOne Medicines Advances CDK4 Cancer Drug With Completion of Key Phase 1 Trial
TipRanks63 · neutralproduct/pr
BeOne Medicines AG (ONC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at ASCO - Slideshow
Seeking Alpha56 · neutralproduct/pr
BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at ASCO Transcript
Seeking Alpha56 · neutralproduct/pr
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 | ONC Stock News
StockTitan73 · bullishproduct/pr
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026 | ONC Stock News
StockTitan73 · bullishproduct/pr
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | ONC Stock News
StockTitan56 · neutralgeneral
Leerink Raises its Price Target on BeOne Medicines (ONC)
Yahoo Top61 · neutralanalyst
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News
StockTitan63 · neutralproduct/pr